Travere Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TVTX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 42.51 M35.72 M42.19 M-4.98 M-14.32 M14.89 M 37.78 M Cash from investing activities 46.13 M-80.31 M41.29 M4.85 M86.59 M-104.84 M 27.89 M Cash from financing activities 46 K139.12 M3.72 M1.48 M54.95 M-26.68 M 33.47 M Free cash flow 34.31 M26.08 M30.41 M-17.07 M-29.36 M-4.35 M -20.37 M

뉴스

Ligand, 로열티 성장 힘입어 4분기 실적 기대치 상회

Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX)

Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript

Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates

Travere Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-02-19

Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss

Travere Therapeutics earnings beat by $0.41, revenue fell short of estimates

트라베어 테라퓨틱스, FSGS 승인 지연 속 실적 시험대

Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday

Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?

Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy?

Travere Therapeutics, 전략적 방향에 자신감 표명